Retroviral vector containing two ribozymes: The NIH Recombinant DNA Advisory Committee exempted a proposed ribozyme study from committee review.

Ribozyme Pharmaceuticals Inc. (RZYM), Boulder, Colo. Product: Retroviral vector containing two ribozymes Indication: HIV Status: The NIH Recombinant DNA Advisory Committee (RAC) exempted a proposed ri...